-+ 0.00%
-+ 0.00%
-+ 0.00%

Ikonisys unit Hospitex signs Uzbekistan oncology institute deal for Urine24 screening study

PUBT·07/23/2026 05:34:22
Listen to the news
Ikonisys unit Hospitex signs Uzbekistan oncology institute deal for Urine24 screening study
  • Ikonisys unit Hospitex International signed an agreement with Uzbekistan’s Oncology Institute to run a feasibility study for a national Urine24 screening program.
  • Scope covers technical, regulatory, operational, financial review for a potential pilot rollout.
  • Parties may pursue an initial implementation phase valued at about EUR 1 million, contingent on positive study results and required approvals.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ikonisys SA published the original content used to generate this news brief on July 23, 2026, and is solely responsible for the information contained therein.